{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/carpal-tunnel-syndrome/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"3c10766e-7fc7-5966-adf7-266504b7b2b8","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field c99280ce-9d22-4292-81f8-b0b86c77d440 --><h2>How common is it?</h2><!-- end field c99280ce-9d22-4292-81f8-b0b86c77d440 -->","summary":"","htmlStringContent":"<!-- begin item bc0b2c1c-7e8d-4a5f-8fa5-b26dfccced94 --><!-- begin field 06247c0a-2851-4195-b961-8e4b148608bc --><ul><li>Carpal tunnel syndrome (CTS) is the most common compression neuropathy of the upper limb [<a class=\"bibliography-reference internal-reference\" href=\"/topics/carpal-tunnel-syndrome/references/\">Middleton and Anakwe, 2014</a>].</li><li>The prevalence of CTS identified in European population studies varies from 1 to 7% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/carpal-tunnel-syndrome/references/\">Ashworth, 2014</a>].</li><li>A mail survey with subsequent clinical examination and nerve conduction testing of symptomatic respondents in Sweden (n = 2,466) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/carpal-tunnel-syndrome/references/\">Atroshi et al, 1999</a>] found that:<ul><li>On clinical examination, the prevalence of clinically certain CTS in symptomatic people was 3.8% (95% CI 3.1–4.6%).</li><li>On nerve conduction testing, the prevalence of median neuropathy at the carpal tunnel in symptomatic people was 4.9% (CI 4.1–5.8%).</li><li>The prevalence of clinically and electrophysiologically confirmed CTS in symptomatic people was 2.7% (CI 2.1–3.4%).</li></ul></li><li>An analysis of data from the Dutch National Survey of General Practice (n = 364,998) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/carpal-tunnel-syndrome/references/\">Bongers et al, 2007</a>] found that:<ul><li>The crude incidence rate was 1.8 per 1000 (95% CI 1.7–2.0) in 2001.</li><li>Peak incidence occurred in people aged 45–64 years. In 2001, the incidence in this age group was 4.8 per 1000 (95% CI 4.1–5.4) for females and 1.6 (95%CI 1.2–2.0) for males [<a class=\"bibliography-reference internal-reference\" href=\"/topics/carpal-tunnel-syndrome/references/\">Bongers et al, 2007</a>].</li></ul></li><li>CTS is three times more common in women than men [<a class=\"bibliography-reference internal-reference\" href=\"/topics/carpal-tunnel-syndrome/references/\">Bongers et al, 2007</a>].</li><li>In the US the prevalence of CTS is estimated to be 0.7/10,000 workers and it is an important cause of reduced productivity [<a class=\"bibliography-reference internal-reference\" href=\"/topics/carpal-tunnel-syndrome/references/\">AAOS, 2016</a>].</li></ul><!-- end field 06247c0a-2851-4195-b961-8e4b148608bc --><!-- end item bc0b2c1c-7e8d-4a5f-8fa5-b26dfccced94 -->","topic":{"id":"414b5174-0792-56b3-9c3e-b1440e29ec6f","topicId":"5c49f319-6d62-40b6-a65b-cc5be1421d2b","topicName":"Carpal tunnel syndrome","slug":"carpal-tunnel-syndrome","lastRevised":"Last revised in September 2020","chapters":[{"id":"ac5321b8-2c09-535b-95bd-ac79b3ec63c7","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"e9515b58-0c18-5d08-ba05-c1fca2079c30","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"7985b1c9-deb7-5e87-8cfa-66e0186b5c0c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"78e08fcf-114e-5617-b696-c6b430a324be","slug":"changes","fullItemName":"Changes"},{"id":"94a13eee-3ae2-5168-9372-2a75e5ae2aa3","slug":"update","fullItemName":"Update"}]},{"id":"3a8760fa-c163-5041-946d-715a7b2249c6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"3951831b-01ad-5088-871e-c94ed84f8be5","slug":"goals","fullItemName":"Goals"},{"id":"ee01f552-6417-5906-890f-62c88aab2389","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"d8cf1322-72d7-5291-bebb-4d4dfb8454c5","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"dd0d1722-7774-5a72-9df9-101613a27222","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"fc34c529-7264-56d1-baae-548d470ebbbd","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"6fdef700-b436-569a-ae98-ef20570c6202","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"2aafa6b7-8c57-5972-b891-aa51b36e795b","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"b4514403-8218-52b9-8703-33dd761e1e27","slug":"definition","fullItemName":"Definition"},{"id":"3c10766e-7fc7-5966-adf7-266504b7b2b8","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e15f995f-1715-59a3-a9d4-b26e48868d17","slug":"causes","fullItemName":"Causes"},{"id":"b4803b19-86dd-50ba-80f0-e8fb12ab09fe","slug":"prognosis","fullItemName":"Prognosis"},{"id":"e3c9e31f-ebe0-57a7-afe2-22940aa45125","slug":"complications","fullItemName":"Complications"}]},{"id":"c94e9f85-5051-579c-9836-d4c218e3f940","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"39f6e890-1099-5e6b-bccb-9145da5d4797","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"d817d9e6-b1df-53a1-b748-58c1c86b7103","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"3c9b7e93-700a-5d61-9083-007df121d11c","fullItemName":"Management","slug":"management","subChapters":[{"id":"58a375f4-d3a2-5350-bd64-4ccb12619107","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"9d62b559-8018-5363-b314-2b2d352a8a4f","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"3180643e-1e36-5feb-af8e-cbcae384e76c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"1716dac4-9c62-58d0-a961-29be37379bc4","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"34e55fd0-970e-5903-b545-de95491ec22f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"4755e5d8-0fb1-5596-bb8d-acd383f1c2ef","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"083b7a8d-dbb3-50f6-8ce4-f98f54b90ea8","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"2c9136a9-561b-5157-9fe4-2c10d67c552b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c1eef5f8-a51f-5764-be06-855d71c099e6","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"2aafa6b7-8c57-5972-b891-aa51b36e795b","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}